For many people, grit – the perseverance and passion for long-term goals – is a virtue. It is also a key ingredient in overcoming challenges, achieving success and maintaining resilience.…
Tag: Alzheimer’s disease
Knowing Alzheimer’s Risk Lowers Anxiety, But Motivation Fades
Summary: A new study shows that learning about amyloid beta buildup — a risk factor for Alzheimer’s disease — does not increase emotional distress, but motivation to maintain healthy habits…
From Anxiety to Alzheimer’s, Music Makes a Difference
Summary: Music therapy is proving to be a powerful adjunct treatment for a range of conditions, including Alzheimer’s disease, chronic pain, movement disorders, and mental health issues. Research highlights how…
Alzheimer’s Study Identifies 16 Risk Genes
Summary: A large whole-genome sequencing study has uncovered 16 new genes linked to Alzheimer’s disease, expanding genetic research beyond European ancestry. Researchers analyzed data from 49,149 individuals, nearly half of…
Brain Bleeds Double Dementia Risk
Summary: Researchers have found that intracranial hemorrhages, or “brain bleeds,” double the risk of developing dementia later in life. While ischemic strokes caused by blood clots have long been linked…
Imaging Reveals Gut-Brain Connection in Alzheimer’s Disease
Summary: Scientists have used advanced X-ray phase-contrast tomography (XPCT) to uncover how gut health may influence Alzheimer’s disease. The study found structural changes in the gut of Alzheimer’s-affected mice, revealing…
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management. The Food and Drug Administration’s…
Vulnerability to financial scams in aging adults could be an early indicator of Alzheimer’s disease, new research shows
A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new…
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Summary: Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in Alzheimer’s disease. This peptide inhibitor, RI-AG03, effectively prevents Tau buildup…
Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns
Summary: The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation. The study highlights multiple patient deaths during trials, design…
